COVID-19 and Indian pharma industry

Authors : G Vidyasagar

DOI : 10.18231/j.ijpp.2021.017

Volume : 8

Issue : 2

Year : 2021

Page No : 100-101


Citation Data


Related Articles

Axillary crystallizing galactocele masqueradingmalignancy:A rare case report andreview of literature

Swati Raj, Abhishek Baunihiyal, Shalini Shah, Naveen Thapliyal

Impact of small group discussions on knowledge and attitudes of resident clinicians towards adverse drug reaction reporting in a tertiary care teaching hospital

Nehal A Shah, Shruti V Brahmbhatt, Sagun Desai

Association between vitamin D status and risk of metabolic syndrome among postmenopausal women in Kerala population

Mirshad P.V, Mumtaz P, Jithesh T.K, Jaideep Mahendra, Prema Gurumurthy

Phytochemical screening and antibacterial activity of Trachyspermum ammi L. against certain bacterial species

Aparajita Gupta*, Mannu Kumari, Shabnam Sharma

Orthodontic practice and management during covid 19 era – A review

Nausheer Ahmed, Abrar Younus A, K Ranjan R Bhat, Rithika Joseph, Nikhil P M, Shreya Shetty K

Radiological profile of multiple sclerosis in a tertiary care center: A study from Eastern India

Biswal N.R, Mallick Ashok K, Mishra Shubhankar

Management of gingival enlargement by medical & non surgical dental therapy in a cerebral palsy patient - A case report

Divya Singh Hada, Subhash Garg, Shaleen Khetarpal, Madhu S. Ratre

Flood dermatoses: A literature review

Joydeep Roy, Kinnor Das, Ann John Kurien

An early experience of Itolizumab with best supportive care in the treatment of moderate to severe COVID-19 patients: A retrospective study

Hemant P Thacker, Dnyaneshwar Halnor, Amit Dhekane, Nivedita Wadhwa, Shalaka Patil, Bhavesh Gandhi, Janardan Nimbolkar, Ajit Avhad